#USA #Washington #ALS Research #Federal funding #I AM ALS

Significant Milestone for ALS Research Funding

I AM ALS has achieved a significant milestone in its Push for Progress campaign, announcing the successful acquisition of $313 million in funding for ALS research from the federal budget for 2026. This brings the total federal funding secured since the organization’s founding in 2019 to an impressive $1.6 billion. The campaign aims to enhance research speed and treatment access for individuals living with Amyotrophic Lateral Sclerosis (ALS).

The announcement of this funding comes at a crucial time, just before the Government Accountability Office (GAO) released a report evaluating the Accelerating Access to Critical Therapies for ALS (ACT for ALS) Act. This report highlighted the substantial benefits of the legislation for both patients and the research community, emphasizing its potential in creating a more coordinated and transparent research environment for ALS. Among its key findings, the GAO pointed out how ACT for ALS not only broadens access to experimental treatments through Expanded Access Programs (EAPs) but also prepares clinics to participate in research, ensuring that more patients can access relevant therapies.

The Road Ahead

Having reached approximately one-third of its ambitious goal of $1 billion for ALS research funding over a three-year period, I AM ALS continues to advocate vigorously for resources that can expedite treatment availability. The organization is committed to encouraging lawmakers to sustain and increase federal investment until viable treatment options and a cure for ALS are within reach.

The overwhelming support from the community of advocates and partners has been the backbone of this initiative. This momentous progress is seen as a beacon of hope for those affected by ALS, pushing the envelope for faster research and more effective treatments.

I AM ALS has redefined the landscape of federal ALS funding by elevating patient perspectives, forging bipartisan support, and persistently pursuing substantial investments. The inspiring advocacy efforts have not only transformed funding streams but also catalyzed significant changes in research directions, funding priorities, and the overall support ecosystem surrounding ALS.

Ongoing Commitments

As the Push for Progress campaign progresses, I AM ALS aims to maintain this momentum by continuing advocacy efforts. With federal funding now totaling over $1.6 billion, the organization is focused on the next milestone—reauthorization of the ACT for ALS act, which plays a pivotal role in uniting stakeholders around a common goal for ALS treatment.

The organization invites anyone interested to engage in this movement by visiting iamals.org/progress and taking action online. With this collaborative endeavor, I AM ALS hopes to fund innovative research breakthroughs that will ultimately transform the lives of those battling ALS.

About I AM ALS

Established in 2019, I AM ALS is a nonprofit organization that focuses on uniting patients, families, and advocates to drive systemic change in the treatment and accessibility of therapies for ALS. Time and again, their approach has been praised as one of the most effective patient advocacy efforts of the current century, bringing together a collective force striving for real advancements in clinical practice and research. By advocating for substantial federal policy changes, enhancing the quality of life for ALS patients, and mobilizing community support, I AM ALS is paving the way for a future where ALS might no longer be an insurmountable challenge.

For updates and further information, please visit www.iamals.org.